These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35989582)

  • 1. Autoimmune nodopathies, an emerging diagnostic category.
    Martín-Aguilar L; Lleixà C; Pascual-Goñi E
    Curr Opin Neurol; 2022 Oct; 35(5):579-585. PubMed ID: 35989582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growing Spectrum of Autoimmune Nodopathies.
    Gupta P; Mirman I; Shahar S; Dubey D
    Curr Neurol Neurosci Rep; 2023 May; 23(5):201-212. PubMed ID: 37014546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of autoantibodies against nodal and paranodal proteins in autoimmune nodopathies].
    Ogata H
    Rinsho Shinkeigaku; 2023 Nov; 63(11):715-724. PubMed ID: 37880115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
    Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
    Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
    Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
    Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
    Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
    Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
    Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test.
    Pascual-Goñi E; Caballero-Ávila M; Querol L
    Neurology; 2024 Aug; 103(4):e209725. PubMed ID: 39088795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
    Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
    Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
    Devaux JJ
    Am J Pathol; 2012 Oct; 181(4):1402-13. PubMed ID: 22885108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neurofascin autoantibody and demyelination.
    Kira JI; Yamasaki R; Ogata H
    Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal proteins are target antigens in Guillain-Barré syndrome.
    Devaux JJ; Odaka M; Yuki N
    J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies.
    Vallat JM; Yuki N; Sekiguchi K; Kokubun N; Oka N; Mathis S; Magy L; Sherman DL; Brophy PJ; Devaux JJ
    Neuromuscul Disord; 2017 Mar; 27(3):290-293. PubMed ID: 27986399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model.
    Doppler K; Schuster Y; Appeltshauser L; Biko L; Villmann C; Weishaupt A; Werner C; Sommer C
    J Neuroinflammation; 2019 Apr; 16(1):73. PubMed ID: 30953561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.
    Zhang L; Zhang Y; Li R; Zhu J; Lin A; Yan Y; Zhang Z; Wang N; Xu G; Fu Y
    J Neurol; 2024 Aug; 271(8):4991-5002. PubMed ID: 38771386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance.
    Vural A; Doppler K; Meinl E
    Front Immunol; 2018; 9():1029. PubMed ID: 29867996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.
    Stathopoulos P; Alexopoulos H; Dalakas MC
    Nat Rev Neurol; 2015 Mar; 11(3):143-56. PubMed ID: 25623793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
    Pascual-Goñi E; Martín-Aguilar L; Querol L
    Curr Opin Neurol; 2019 Oct; 32(5):651-657. PubMed ID: 31306213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.
    Querol L; Devaux J; Rojas-Garcia R; Illa I
    Nat Rev Neurol; 2017 Sep; 13(9):533-547. PubMed ID: 28708133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.